Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.

Autor:	Sandbrink, Julian D., Johnson, Kyle, Gill, Maureen, Yaden, David B., Savulescu, Julian, Hannikainen, Ivar R., Earp, Brian D.
Předmět:	MENTAL illness drug therapy MENTAL health CONTROLLED substances HEALTH policy HALLUCINOGENIC drugs PUBLIC opinion ETHICAL decision making HEALTH promotion JUDGMENT (Psychology) DRUG laws WELL-being PATIENTS' attitudes ETHICS
Zdroj:	AJOB Neuroscience; Apr-Jun2024, Vol. 15 Issue 2, p82-89, 8p
Abstrakt:	The psychedelic psilocybin has shown promise both as treatment for psychiatric conditions and as a means of improving well-being in healthy individuals. In some jurisdictions (e.g., Oregon, USA), psilocybin use for both purposes is or will soon be allowed and yet, public attitudes toward this shift are understudied. We asked a nationally representative sample of 795 US Americans to evaluate the moral status of psilocybin use in an appropriately licensed setting for either treatment of a psychiatric condition or well-being enhancement. Showing strong bipartisan support, participants rated the individual's decision as morally positive in both contexts. These results can inform effective policy-making decisions around supervised psilocybin use, given robust public attitudes as elicited in the context of an innovative regulatory model. We did not explore attitudes to psilocybin use in unsupervised or non-licensed community or social settings. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu